Webinar: Transplant Patient Journey Around Infectious Diseases

Transplant recipients must take anti-rejection medications in order to suppress their immune system and prevent rejection of the new organ. A suppressed immune system results in a higher risk of getting infections and having more difficulties in fighting against them. Anti-rejection medications may prevent the body from responding well to vaccines. While minor infections are common after a transplant, they can become serious if the patient has other chronic conditions, which can increase the risks of infection, including lung disease, heart disease, or diabetes.

This webinar aims to increase patient awareness against the risks of infectious diseases through talks by experienced patient advocates and empower them to address their concerns with their healthcare professionals.

Learning Objectives:

Viewers will learn:

• How to best convey their concerns around infectious diseases with their doctors

• Communication when in the emergency room

• Best ways to make use of the My Life – my health tool kit box to guide you through your transplant journey

For more information on ESOT’s Patient advocacy and awareness project, please click here.

Scientific Organisers:

• Penilla Gunther (Sweden)

• Bill Scott (United Kingdom)

• Fiona Loud (United Kingdom)

• Fernanda Ortiz (Finland)

Note: Participants will be able to make use of simultaneous subtitles to translate the webinar in the language of their choice.

This activity has been developed under a healthcare collaboration between the European Society for Organ Transplantation (ESOT) and Takeda that aims to benefit patient care. All content has been developed independently by ESOT.